Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 4,104 | 5,590 | 2,095 | 1,993 | 2,501 |
| Operating Income | -4,104 | -5,590 | -2,095 | -1,993 | -2,501 |
| Other Income | 95 | 44 | 530 | 759 | -635 |
| Pre-tax Income | -4,009 | -5,546 | -1,565 | -1,234 | -3,136 |
| Income Tax | 0 | -40 | -62 | 6 | 3 |
| Net Income Continuous | -4,009 | -5,506 | -1,503 | -1,240 | -3,139 |
| Net Income | $-4,009 | $-5,506 | $-1,503 | $-1,240 | $-3,139 |
| EPS Basic Total Ops | -3.40 | -6.95 | 20.70 | -3.75 | -15.19 |
| EPS Basic Continuous Ops | -3.39 | -6.95 | 20.87 | -3.77 | -15.16 |
| EPS Diluted Total Ops | -3.40 | -6.95 | 20.70 | -3.75 | -15.19 |
| EPS Diluted Continuous Ops | -3.39 | -6.95 | 20.87 | -3.77 | -15.16 |
| EPS Diluted Before Non-Recurring Items | -3.40 | -6.95 | -0.25 | -3.75 | -15.25 |
| EBITDA(a) | $-4,060 | $-3,460 | $-2,026 | $-1,923 | $-2,446 |